-
Something wrong with this record ?
Increased oxidative/nitrosative stress markers measured non- invasively in patients with high 2,3,7,8-tetrachloro-dibenzo-p-dioxin plasma level
Daniela Pelclova, Tomas Navratil, Zdenka Fenclova, Stepanka Vlckova, Karel Kupka, Pavel Urban, Petr Ridzon, Vit Zikan, Ludmila Landova, Kamila Syslova, Marek Kuzma, Petr Kacer
Language English Country Sweden
Document type Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't
Grant support
NS10298
MZ0
CEP Register
PubMed
22167218
Knihovny.cz E-resources
- MeSH
- Urinalysis methods MeSH
- Blood Chemical Analysis methods MeSH
- Biomarkers analysis blood urine MeSH
- Chemical Industry MeSH
- Herbicides analysis blood MeSH
- Middle Aged MeSH
- Humans MeSH
- Osmolar Concentration MeSH
- Oxidative Stress physiology MeSH
- Polychlorinated Dibenzodioxins analogs & derivatives analysis blood MeSH
- Occupational Exposure analysis MeSH
- Reactive Nitrogen Species analysis blood metabolism urine MeSH
- Reactive Oxygen Species analysis blood metabolism urine MeSH
- Aged MeSH
- Case-Control Studies MeSH
- Up-Regulation MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Evaluation Study MeSH
- Research Support, Non-U.S. Gov't MeSH
OBJECTIVES: 2,3,7,8-tetrachloro-dibenzo-p-dioxin (TCDD) is a highly toxic persistent environmental contaminant, classified as a human carcinogen affecting any target organ. The mechanism of carcinogenesis by TCDD is unclear as TCDD shows a lack of direct genotoxicity. Experimental studies also support the role of oxidative stress in TCDD neurotoxicity and vascular dysfunction. The aim was to investigate markers of oxidative/nitrosative stress and inflammation using non-invasive methods in subjects who got ill due to severe occupational exposure to TCDD in the years 1965-1968. METHODS: In 11 TCDD-exposed patients, and 16 controls, the analysis of following oxidative products of lipids, proteins and nucleic acids in plasma, urine and exhaled breath condensate (EBC) was performed: 8-iso-prostaglandin F2α (8-isoprostane), 4-hydroxy-trans-2-nonenale (HNE), malondialdehyde (MDA), o-tyrosine (o-Tyr), 8-hydroxyguanosine (8-OHG), 8-hydroxy-2 ́-deoxy-guanosine (8-OHdG), 5-hydroxymethyluracil (5-OHMeU). In addition, nitric-oxide-tyrosine (NO-Tyr) and leukotriene (LT) B4, C4, D4, and E4 were detected by liquid chromatography-mass spectrometry/mass spectrometry (LC-ESI-MS/MS). TCDD was measured by HRGC/HRMS, body lipid content by densitometry. Single-photon emission spectrometry (SPECT) of the brain was performed and compared with the findings of the patients in 2008. RESULTS: Mean TCDD plasma level in 2010 was 175 ± 162 pg/g lipids (population level about 2 pg/g), total TCDD content in the body 5.16 ± 4.62 mg. Reduction of cerebral blood flow in SPECT progressed in 8 patients, finding was stable in 2 subjects, and improvement occurred in 1 patient. In the EBC, 10 from 12 markers (all except LT D4 and LT E4), were significantly increased in the patients (p<0.05). In the urine, 7 markers were significantly higher than in the controls (p<0.05): 8-isoprostane, MDA, HNE, LT C4, LT E4, o-Tyr and NO-Tyr. In plasma, only NO-Tyr and 8-OHG were elevated (p<0.05). CONCLUSION: NO-Tyr was increased in all matrices in dioxin-exposed patients. EBC is not limited to lung disorders as the markers of oxidative stress and inflammation were elevated in EBC of patients with normal lung functions. TCDD-induced oxidative stress and inflammation markers can be detected non-invasively in the EBC and urine in the follow-up of the highly-exposed patients. Their prognostic value, however, needs to be elucidated.
Institute of Chemical Technology Prague Czech Republic
Institute of Microbiology AS CR v v i Prague Czech Republic
J Heyrovský Institute of Physical Chemistry of AS CR v v i Prague Czech Republic
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12024190
- 003
- CZ-PrNML
- 005
- 20250403090647.0
- 007
- ta
- 008
- 120815s2011 sw f 000 0#eng||
- 009
- AR
- 035 __
- $a (PubMed)22167218
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sw
- 100 1_
- $a Pelclová, Daniela, $d 1953- $7 nlk20010096163 $u Department of Occupational Medicine, 1st Medical Faculty, Charles University and General University Hospital, Prague, Czech Republicc. daniela.pelclova@LF1.cuni.cz
- 245 10
- $a Increased oxidative/nitrosative stress markers measured non- invasively in patients with high 2,3,7,8-tetrachloro-dibenzo-p-dioxin plasma level / $c Daniela Pelclova, Tomas Navratil, Zdenka Fenclova, Stepanka Vlckova, Karel Kupka, Pavel Urban, Petr Ridzon, Vit Zikan, Ludmila Landova, Kamila Syslova, Marek Kuzma, Petr Kacer
- 520 9_
- $a OBJECTIVES: 2,3,7,8-tetrachloro-dibenzo-p-dioxin (TCDD) is a highly toxic persistent environmental contaminant, classified as a human carcinogen affecting any target organ. The mechanism of carcinogenesis by TCDD is unclear as TCDD shows a lack of direct genotoxicity. Experimental studies also support the role of oxidative stress in TCDD neurotoxicity and vascular dysfunction. The aim was to investigate markers of oxidative/nitrosative stress and inflammation using non-invasive methods in subjects who got ill due to severe occupational exposure to TCDD in the years 1965-1968. METHODS: In 11 TCDD-exposed patients, and 16 controls, the analysis of following oxidative products of lipids, proteins and nucleic acids in plasma, urine and exhaled breath condensate (EBC) was performed: 8-iso-prostaglandin F2α (8-isoprostane), 4-hydroxy-trans-2-nonenale (HNE), malondialdehyde (MDA), o-tyrosine (o-Tyr), 8-hydroxyguanosine (8-OHG), 8-hydroxy-2 ́-deoxy-guanosine (8-OHdG), 5-hydroxymethyluracil (5-OHMeU). In addition, nitric-oxide-tyrosine (NO-Tyr) and leukotriene (LT) B4, C4, D4, and E4 were detected by liquid chromatography-mass spectrometry/mass spectrometry (LC-ESI-MS/MS). TCDD was measured by HRGC/HRMS, body lipid content by densitometry. Single-photon emission spectrometry (SPECT) of the brain was performed and compared with the findings of the patients in 2008. RESULTS: Mean TCDD plasma level in 2010 was 175 ± 162 pg/g lipids (population level about 2 pg/g), total TCDD content in the body 5.16 ± 4.62 mg. Reduction of cerebral blood flow in SPECT progressed in 8 patients, finding was stable in 2 subjects, and improvement occurred in 1 patient. In the EBC, 10 from 12 markers (all except LT D4 and LT E4), were significantly increased in the patients (p<0.05). In the urine, 7 markers were significantly higher than in the controls (p<0.05): 8-isoprostane, MDA, HNE, LT C4, LT E4, o-Tyr and NO-Tyr. In plasma, only NO-Tyr and 8-OHG were elevated (p<0.05). CONCLUSION: NO-Tyr was increased in all matrices in dioxin-exposed patients. EBC is not limited to lung disorders as the markers of oxidative stress and inflammation were elevated in EBC of patients with normal lung functions. TCDD-induced oxidative stress and inflammation markers can be detected non-invasively in the EBC and urine in the follow-up of the highly-exposed patients. Their prognostic value, however, needs to be elucidated.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a biologické markery $x analýza $x krev $x moč $7 D015415
- 650 _2
- $a biochemická analýza krve $x metody $7 D001774
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a chemický průmysl $7 D002617
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a herbicidy $x analýza $x krev $7 D006540
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a pracovní expozice $x analýza $7 D016273
- 650 _2
- $a osmolární koncentrace $7 D009994
- 650 _2
- $a oxidační stres $x fyziologie $7 D018384
- 650 _2
- $a reaktivní formy dusíku $x analýza $x krev $x metabolismus $x moč $7 D026361
- 650 _2
- $a reaktivní formy kyslíku $x analýza $x krev $x metabolismus $x moč $7 D017382
- 650 _2
- $a polychlorované dibenzodioxiny $x analogy a deriváty $x analýza $x krev $7 D000072317
- 650 _2
- $a upregulace $7 D015854
- 650 _2
- $a analýza moči $x metody $7 D016482
- 655 _2
- $a hodnotící studie $7 D023362
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Navrátil, Tomas $u J. Heyrovský Institute of Physical Chemistry of AS CR, v.v.i., Prague, Czech Republic
- 700 1_
- $a Fenclová, Zdeňka, $d 1958- $u Department of Occupational Medicine, 1st Medical Faculty, Charles University and General University Hospital, Prague, Czech Republic $7 xx0074215
- 700 1_
- $a Vlčková, Štěpánka $7 xx0162780 $u Department of Occupational Medicine, 1st Medical Faculty, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Kupka, Karel $u Institute of Nuclear Medicine, 1st Medical Faculty, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Urban, Pavel $u Department of Occupational Medicine, 1st Medical Faculty, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Ridzon, Petr $u Department of Occupational Medicine, 1st Medical Faculty, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Zikan, Vit $u 3rd Medical Department, 1st Medical Faculty, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Landová, Ludmila $u Institute of Clinical Chemistry and Laboratory Diagnostics Faculty, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Syslová, Kamila $u Institute of Chemical Technology, Prague, Czech Republic
- 700 1_
- $a Kuzma, Marek $u Institute of Microbiology, AS CR, v.v.i., Prague, Czech Republic
- 700 1_
- $a Kačer, Petr $u Institute of Chemical Technology, Prague, Czech Republic
- 773 0_
- $w MED00168352 $t Neuro-endocrinology letters $x 0172-780X $g Roč. 32 Suppl 1 (2011), s. 71-76
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22167218 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120815 $b ABA008
- 991 __
- $a 20250403090643 $b ABA008
- 999 __
- $a ok $b bmc $g 946338 $s 781518
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 32 Suppl 1 $d 71-76 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
- GRA __
- $a NS10298 $p MZ0
- LZP __
- $a Pubmed-20120815/12/02